The Role of CDH1 -160 C/A Polymorphism in Gastric Cancer Metastasis: A Molecular Perspective
Anatomy and Histology Journal of Indonesia · 26.06.2026 · 2 (1) · 1-11
DOI: 10.51559/8sh7fp11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anatomy and Histology Journal of Indonesia, online erschienen am 26.06.2026. Verfasst von Ida Bagus Gede Ari Suryawan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Primary gastric cancer is a formidable, biologically heterogeneous malignancy globally. Among its distinct histopathological subtypes, diffuse gastric cancer (DGC) is notoriously aggressive, characterized by extensive metastatic dissemination, profound therapeutic resistance, and devastating mortality. A foundational molecular defect driving this highly invasive phenotype is the loss of E-cadherin, a transmembrane glycoprotein encoded by the CDH1 tumor suppressor gene (chromosome 16q22.1). This systematic review elucidates the structural, molecular, and epigenetic implications of the CDH1 -160 C/A promoter polymorphism (rs16260), a critical genetic variant that significantly attenuates baseline transcription. This cytosine-to-adenine transversion alters the binding landscape for activating transcription factors (Sp1 and AP-2) while creating aberrant binding sites for transcriptional repressors. Furthermore, the variant -160A allele facilitates a lethal epigenetic silencing cascade mediated by non-coding sense promoter-associated RNAs (S-paRNAs), microRNA isomiR-4534, Argonaute 1 (AGO1), and histone methyltransferase SUV39H1, locking the CDH1 promoter in a hypermethylated state via DNMT recruitment. The resultant depletion of E-cadherin collapses epithelial adherens junctions, leading to the highly motile, signet ring morphology characteristic of linitis plastica. Concomitantly, the dissolution of E-cadherin scaffolding releases β-catenin into the cytoplasm, hyperactivating canonical Wnt/β-catenin signaling to drive proliferation, while non-canonical cytoskeletal dynamics driven by p120-catenin, Rac1, and mutant RhoA (Y42C) are rewired to promote motility. These synergistic cascades precipitate Epithelial-Mesenchymal Transition (EMT), driving lineage plasticity requisite for invasion. Finally, this report highlights translational precision oncology strategies targeting ROS1/FAK synthetic lethality, Wnt/β-catenin inhibition, and epigenetic reactivation via DNA demethylating agents.
Zitieren
APA
Suryawan, I. B. G. A., Divasta, I. G. M., Sasmana, I. G. A. P., & Supadmanaba, I. G. P. (2026). The Role of CDH1 -160 C/A Polymorphism in Gastric Cancer Metastasis: A Molecular Perspective. Anatomy and Histology Journal of Indonesia, 2(1), 1-11. https://doi.org/10.51559/8sh7fp11
Vancouver
Suryawan IBGA, Divasta IGM, Sasmana IGAP, Supadmanaba IGP. The Role of CDH1 -160 C/A Polymorphism in Gastric Cancer Metastasis: A Molecular Perspective. Anatomy and Histology Journal of Indonesia. 2026;2(1):1-11. doi:10.51559/8sh7fp11
BibTeX
@article{Suryawan2026,
author = {Suryawan, Ida Bagus Gede Ari and Divasta, I G Mahapraja and Sasmana, I Gede Aswin Parisya and Supadmanaba, I Gede Putu},
title = {The Role of CDH1 -160 C/A Polymorphism in Gastric Cancer Metastasis: A Molecular Perspective},
journal = {Anatomy and Histology Journal of Indonesia},
year = {2026},
volume = {2},
number = {1},
pages = {1--11},
doi = {10.51559/8sh7fp11}
}
EUVIMED